184 related articles for article (PubMed ID: 30639280)
1. Insulin analogs: Glimpse on contemporary facts and future prospective.
Sharma AK; Taneja G; Kumar A; Sahu M; Sharma G; Kumar A; Sardana S; Deep A
Life Sci; 2019 Feb; 219():90-99. PubMed ID: 30639280
[TBL] [Abstract][Full Text] [Related]
2. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
Ilag LL; Kerr L; Malone JK; Tan MH
Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
[TBL] [Abstract][Full Text] [Related]
3. Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practice.
Goldman J; Kapitza C; Pettus J; Heise T
Curr Med Res Opin; 2017 Oct; 33(10):1821-1831. PubMed ID: 28537449
[TBL] [Abstract][Full Text] [Related]
4. Insulin analogues for type 1 diabetes in children and adolescents.
Galli-Tsinopoulou A; Stergidou D
Drugs Today (Barc); 2012 Dec; 48(12):795-809. PubMed ID: 23243636
[TBL] [Abstract][Full Text] [Related]
5. New Long-Acting Basal Insulins: Does Benefit Outweigh Cost?
Standl E; Owen DR
Diabetes Care; 2016 Aug; 39 Suppl 2():S172-9. PubMed ID: 27440830
[No Abstract] [Full Text] [Related]
6. Insulin analogues.
Marks J
Postgrad Med; 2002 Nov; 112(5 Suppl Designer):8-12. PubMed ID: 19667599
[TBL] [Abstract][Full Text] [Related]
7. [Insulin analogues: searching for a physiological replacement].
Eyzaguirre F; Codner E
Rev Med Chil; 2006 Feb; 134(2):239-50. PubMed ID: 16554934
[TBL] [Abstract][Full Text] [Related]
8. Beyond the era of NPH insulin--long-acting insulin analogs: chemistry, comparative pharmacology, and clinical application.
Owens DR; Bolli GB
Diabetes Technol Ther; 2008 Oct; 10(5):333-49. PubMed ID: 18715209
[TBL] [Abstract][Full Text] [Related]
9. Will the next generation of basal insulins offer clinical advantages?
Garber AJ
Diabetes Obes Metab; 2014 Jun; 16(6):483-91. PubMed ID: 24118819
[TBL] [Abstract][Full Text] [Related]
10. The role of the new basal insulin analogs in addressing unmet clinical needs in people with type 1 and type 2 diabetes.
Lajara R; Cengiz E; Tanenberg RJ
Curr Med Res Opin; 2017 Jun; 33(6):1045-1055. PubMed ID: 28277867
[TBL] [Abstract][Full Text] [Related]
11. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
Peterson GE
Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
[TBL] [Abstract][Full Text] [Related]
12. Insulin analogs-are they worth it? Yes!
Grunberger G
Diabetes Care; 2014 Jun; 37(6):1767-70. PubMed ID: 24855159
[TBL] [Abstract][Full Text] [Related]
13. Insulin glargine: a new basal insulin.
Levien TL; Baker DE; White JR; Campbell RK
Ann Pharmacother; 2002 Jun; 36(6):1019-27. PubMed ID: 12022906
[TBL] [Abstract][Full Text] [Related]
14. Prandial Insulins: A Person-Centered Choice.
Attri B; Nagendra L; Dutta D; Shetty S; Shaikh S; Kalra S; Bhattacharya S
Curr Diab Rep; 2024 Jun; 24(6):131-145. PubMed ID: 38568467
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Efficacy and Safety of Insulin Detemir and Insulin Glargine in Hospitalized Patients with Type 2 Diabetes: A Randomized Crossover Trial.
Zhang T; Lin M; Li W; Fan X; Du T; Zhao Y; Zhang X
Adv Ther; 2016 Feb; 33(2):178-85. PubMed ID: 26809253
[TBL] [Abstract][Full Text] [Related]
16. Insulin analogs--is there a compelling case to use them? No!
Davidson MB
Diabetes Care; 2014 Jun; 37(6):1771-4. PubMed ID: 24855160
[TBL] [Abstract][Full Text] [Related]
17. Insulins NPH, glargine, and detemir, and risk of severe hypoglycemia among working-age adults.
Strandberg AY; Khanfir H; Mäkimattila S; Saukkonen T; Strandberg TE; Hoti F
Ann Med; 2017 Jun; 49(4):357-364. PubMed ID: 28042719
[TBL] [Abstract][Full Text] [Related]
18. A patient centred approach to basal insulin choice for the management of type 2 diabetes mellitus.
Kalra S; Gupta Y
J Pak Med Assoc; 2016 Mar; 66(3):360-1. PubMed ID: 26968297
[TBL] [Abstract][Full Text] [Related]
19. Insulin analogues: new therapies for type 2 diabetes mellitus.
Bethel MA; Feinglos MN
Curr Diab Rep; 2002 Oct; 2(5):403-8. PubMed ID: 12643165
[TBL] [Abstract][Full Text] [Related]
20. Role of ultrafast-acting insulin analogues in the management of diabetes.
Kruger DF; Novak LM
J Am Assoc Nurse Pract; 2019 Sep; 31(9):537-548. PubMed ID: 31385938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
